v3.25.4
Acquisitions - Schedule of Fair Values of Consideration Paid (Details) - Beckley Psytech [Member]
$ in Thousands
Nov. 05, 2025
USD ($)
Business Combinations [Line Items]  
Share consideration issued to the Sellers $ 450,476 [1]
Settlement of the unsecured promissory note 10,280 [2]
Settlement of payable to Beckley Psytech (238) [3]
Estimated Fair Value of Stock Options Issued as Replacement Awards 5,455 [4]
Incremental fair value of atai restricted stock units issued for consideration at closing that is attributable to the post-combination entity (328) [5]
Total fair value of consideration paid 465,645 [1]
Reported value of atai's previously held interest in Beckley Psytech 53,947 [6]
Business Combination, Consideration Transferred, Total $ 519,592
[1] Represents the aggregate fair value of 93,580,831 common shares of the Company issued directly to the Sellers as equity consideration and 6,971,912 RSUs issued as replacement awards on the Acquisition Date, based on the closing trading price of the Company’s common share of $4.48 per share on the Acquisition Date.
[2] Represents the settlement of an unsecured promissory note issued by the Company to Beckley Psytech and related accrued interest of $10.3 million (refer to Note 7, Notes Receivable, for more information).
[3] Represents the settlement of accounts payable to Beckley Psytech of $0.2 million on the Acquisition Date, as these pre-existing relationships became intercompany and were effectively settled upon completion of the Beckley Psytech Acquisition.
[4] Represents the fair value of 1,546,258 stock options issued at replacement awards on the Acquisition Date. The Company estimated the fair value of the stock options using the Black-Scholes option-pricing model on the Acquisition Date. The assumptions used in the Black-Scholes option pricing model were as follows:

 

Weighted average expected term in years

 

2.16

Weighted average expected stock price volatility

 

89.5%

Risk-free interest rate

 

3.63% - 3.79%

Expected dividend yield

 

0%
[5] Represents the incremental fair value of 6,971,912 atai restricted stock units issued as replacement awards that is attributable to the post-combination entity.
[6] Represents the reported amount of the Company’s previously held interests in Beckley Psytech, including the carrying value of the Company’s pre-existing investment in Series C Shares of $45.5 million and the carrying value of the Company’s outstanding Series C Warrants of $8.5 million on the Acquisition Date. Refer to Note 6, Investments, for more information.